Logo image of DCBO.CA

DOCEBO INC (DCBO.CA) Stock Fundamental Analysis

Canada - TSX:DCBO - CA25609L1058 - Common Stock

42.03 CAD
+0.18 (+0.43%)
Last: 9/15/2025, 7:00:00 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to DCBO. DCBO was compared to 64 industry peers in the Software industry. DCBO is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. DCBO is not priced too expensively while it is growing strongly. Keep and eye on this one! This makes DCBO very considerable for growth investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

DCBO had positive earnings in the past year.
DCBO had a positive operating cash flow in the past year.
In multiple years DCBO reported negative net income over the last 5 years.
Of the past 5 years DCBO 4 years had a positive operating cash flow.
DCBO.CA Yearly Net Income VS EBIT VS OCF VS FCFDCBO.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

1.2 Ratios

The Return On Assets of DCBO (12.51%) is better than 89.06% of its industry peers.
Looking at the Return On Equity, with a value of 61.75%, DCBO belongs to the top of the industry, outperforming 95.31% of the companies in the same industry.
DCBO's Return On Invested Capital of 32.53% is amongst the best of the industry. DCBO outperforms 96.88% of its industry peers.
Industry RankSector Rank
ROA 12.51%
ROE 61.75%
ROIC 32.53%
ROA(3y)6.1%
ROA(5y)2.04%
ROE(3y)18.51%
ROE(5y)8.92%
ROIC(3y)N/A
ROIC(5y)N/A
DCBO.CA Yearly ROA, ROE, ROICDCBO.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 150

1.3 Margins

With an excellent Profit Margin value of 9.29%, DCBO belongs to the best of the industry, outperforming 84.38% of the companies in the same industry.
DCBO has a better Operating Margin (9.67%) than 78.13% of its industry peers.
DCBO's Gross Margin of 81.00% is amongst the best of the industry. DCBO outperforms 89.06% of its industry peers.
DCBO's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 9.67%
PM (TTM) 9.29%
GM 81%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.38%
GM growth 5Y0.22%
DCBO.CA Yearly Profit, Operating, Gross MarginsDCBO.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 80

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), DCBO is creating value.
DCBO has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for DCBO has been increased compared to 5 years ago.
Compared to 1 year ago, DCBO has an improved debt to assets ratio.
DCBO.CA Yearly Shares OutstandingDCBO.CA Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
DCBO.CA Yearly Total Debt VS Total AssetsDCBO.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

An Altman-Z score of 3.85 indicates that DCBO is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.85, DCBO is in the better half of the industry, outperforming 64.06% of the companies in the same industry.
DCBO has a debt to FCF ratio of 0.05. This is a very positive value and a sign of high solvency as it would only need 0.05 years to pay back of all of its debts.
DCBO has a Debt to FCF ratio of 0.05. This is amongst the best in the industry. DCBO outperforms 93.75% of its industry peers.
A Debt/Equity ratio of 0.01 indicates that DCBO is not too dependend on debt financing.
DCBO has a better Debt to Equity ratio (0.01) than 78.13% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.05
Altman-Z 3.85
ROIC/WACC3.12
WACC10.41%
DCBO.CA Yearly LT Debt VS Equity VS FCFDCBO.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

DCBO has a Current Ratio of 1.04. This is a normal value and indicates that DCBO is financially healthy and should not expect problems in meeting its short term obligations.
DCBO's Current ratio of 1.04 is in line compared to the rest of the industry. DCBO outperforms 46.88% of its industry peers.
DCBO has a Quick Ratio of 1.04. This is a normal value and indicates that DCBO is financially healthy and should not expect problems in meeting its short term obligations.
DCBO has a Quick ratio (1.04) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.04
Quick Ratio 1.04
DCBO.CA Yearly Current Assets VS Current LiabilitesDCBO.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 103.70% over the past year.
Looking at the last year, DCBO shows a quite strong growth in Revenue. The Revenue has grown by 15.11% in the last year.
DCBO shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 39.25% yearly.
EPS 1Y (TTM)103.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%93.33%
Revenue 1Y (TTM)15.11%
Revenue growth 3Y27.67%
Revenue growth 5Y39.25%
Sales Q2Q%14.47%

3.2 Future

The Earnings Per Share is expected to grow by 27.76% on average over the next years. This is a very strong growth
Based on estimates for the next years, DCBO will show a very strong growth in Revenue. The Revenue will grow by 24.94% on average per year.
EPS Next Y35.45%
EPS Next 2Y32.13%
EPS Next 3Y34.47%
EPS Next 5Y27.76%
Revenue Next Year11.22%
Revenue Next 2Y9.78%
Revenue Next 3Y9.84%
Revenue Next 5Y24.94%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
DCBO.CA Yearly Revenue VS EstimatesDCBO.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M
DCBO.CA Yearly EPS VS EstimatesDCBO.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 27.65 indicates a quite expensive valuation of DCBO.
Based on the Price/Earnings ratio, DCBO is valued cheaply inside the industry as 81.25% of the companies are valued more expensively.
DCBO's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.20.
Based on the Price/Forward Earnings ratio of 20.25, the valuation of DCBO can be described as rather expensive.
Based on the Price/Forward Earnings ratio, DCBO is valued a bit cheaper than the industry average as 78.13% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of DCBO to the average of the S&P500 Index (22.71), we can say DCBO is valued inline with the index average.
Industry RankSector Rank
PE 27.65
Fwd PE 20.25
DCBO.CA Price Earnings VS Forward Price EarningsDCBO.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

DCBO's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. DCBO is cheaper than 65.63% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of DCBO indicates a somewhat cheap valuation: DCBO is cheaper than 73.44% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 32.47
EV/EBITDA 31.58
DCBO.CA Per share dataDCBO.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of DCBO may justify a higher PE ratio.
A more expensive valuation may be justified as DCBO's earnings are expected to grow with 34.47% in the coming years.
PEG (NY)0.78
PEG (5Y)N/A
EPS Next 2Y32.13%
EPS Next 3Y34.47%

0

5. Dividend

5.1 Amount

No dividends for DCBO!.
Industry RankSector Rank
Dividend Yield N/A

DOCEBO INC

TSX:DCBO (9/15/2025, 7:00:00 PM)

42.03

+0.18 (+0.43%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-08 2025-08-08/bmo
Earnings (Next)11-06 2025-11-06
Inst Owners36.86%
Inst Owner ChangeN/A
Ins Owners1.46%
Ins Owner ChangeN/A
Market Cap1.21B
Analysts78.67
Price Target41.36 (-1.59%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)27.06%
Min EPS beat(2)26.05%
Max EPS beat(2)28.07%
EPS beat(4)3
Avg EPS beat(4)41.65%
Min EPS beat(4)-25.3%
Max EPS beat(4)137.79%
EPS beat(8)7
Avg EPS beat(8)31.82%
EPS beat(12)10
Avg EPS beat(12)131.11%
EPS beat(16)13
Avg EPS beat(16)110.84%
Revenue beat(2)1
Avg Revenue beat(2)-0.14%
Min Revenue beat(2)-1.61%
Max Revenue beat(2)1.34%
Revenue beat(4)2
Avg Revenue beat(4)-0.11%
Min Revenue beat(4)-1.61%
Max Revenue beat(4)1.34%
Revenue beat(8)2
Avg Revenue beat(8)-0.44%
Revenue beat(12)2
Avg Revenue beat(12)-0.71%
Revenue beat(16)3
Avg Revenue beat(16)-0.87%
PT rev (1m)3.17%
PT rev (3m)1.77%
EPS NQ rev (1m)9.81%
EPS NQ rev (3m)6.52%
EPS NY rev (1m)-2.91%
EPS NY rev (3m)-2.91%
Revenue NQ rev (1m)0.32%
Revenue NQ rev (3m)-3.05%
Revenue NY rev (1m)1.25%
Revenue NY rev (3m)-0.48%
Valuation
Industry RankSector Rank
PE 27.65
Fwd PE 20.25
P/S 3.79
P/FCF 32.47
P/OCF 30.93
P/B 25.19
P/tB 46.47
EV/EBITDA 31.58
EPS(TTM)1.52
EY3.62%
EPS(NY)2.08
Fwd EY4.94%
FCF(TTM)1.29
FCFY3.08%
OCF(TTM)1.36
OCFY3.23%
SpS11.09
BVpS1.67
TBVpS0.9
PEG (NY)0.78
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 12.51%
ROE 61.75%
ROCE 55.51%
ROIC 32.53%
ROICexc N/A
ROICexgc N/A
OM 9.67%
PM (TTM) 9.29%
GM 81%
FCFM 11.67%
ROA(3y)6.1%
ROA(5y)2.04%
ROE(3y)18.51%
ROE(5y)8.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.38%
GM growth 5Y0.22%
F-Score8
Asset Turnover1.35
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.05
Debt/EBITDA 0.01
Cap/Depr 39.68%
Cap/Sales 0.58%
Interest Coverage 250
Cash Conversion 110.06%
Profit Quality 125.62%
Current Ratio 1.04
Quick Ratio 1.04
Altman-Z 3.85
F-Score8
WACC10.41%
ROIC/WACC3.12
Cap/Depr(3y)34.45%
Cap/Depr(5y)55.59%
Cap/Sales(3y)0.56%
Cap/Sales(5y)1.02%
Profit Quality(3y)220.57%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)103.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%93.33%
EPS Next Y35.45%
EPS Next 2Y32.13%
EPS Next 3Y34.47%
EPS Next 5Y27.76%
Revenue 1Y (TTM)15.11%
Revenue growth 3Y27.67%
Revenue growth 5Y39.25%
Sales Q2Q%14.47%
Revenue Next Year11.22%
Revenue Next 2Y9.78%
Revenue Next 3Y9.84%
Revenue Next 5Y24.94%
EBIT growth 1Y84.74%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year120.45%
EBIT Next 3Y50.2%
EBIT Next 5Y32.58%
FCF growth 1Y380.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y338.61%
OCF growth 3YN/A
OCF growth 5YN/A